Literature DB >> 17002485

Anticoagulation for stroke prevention: high effectiveness, more cost benefit?

Eduard Shantsila1, Timothy Watson, Gregory Y H Lip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17002485     DOI： 10.2165/00019053-200624100-00010

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  21 in total

1.  Oral anticoagulation and risk of death: a medical record linkage study.

Authors:  Anders Odén; Martin Fahlén
Journal:  BMJ       Date:  2002-11-09

2.  Prediction of length of stay of first-ever ischemic stroke.

Authors:  Ku-Chou Chang; Mei-Chiun Tseng; Hsu-Huei Weng; Yin-Hui Lin; Chia-Wei Liou; Teng-Yeow Tan
Journal:  Stroke       Date:  2002-11       Impact factor: 7.914

3.  Self management of oral anticoagulation: randomised trial.

Authors:  D A Fitzmaurice; E T Murray; D McCahon; R Holder; J P Raftery; S Hussain; H Sandhar; F D R Hobbs
Journal:  BMJ       Date:  2005-10-10

Review 4.  Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated?

Authors:  Paul S J Miller; Fredrik L Andersson; Lalit Kalra
Journal:  Stroke       Date:  2005-01-06       Impact factor: 7.914

5.  The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.

Authors:  Patrick W Sullivan; Thomas W Arant; Samuel L Ellis; Heather Ulrich
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 6.  Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

Authors:  M Aguilar; R Hart
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

7.  A comparison of the costs and survival of hospital-admitted stroke patients across Europe.

Authors:  R Grieve; J Hutton; A Bhalla; D Rastenytë; D Ryglewicz; C Sarti; M Lamassa; M Giroud; R Dundas; C D Wolfe
Journal:  Stroke       Date:  2001-07       Impact factor: 7.914

8.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors:  E Chiquette; M G Amato; H I Bussey
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

9.  Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK.

Authors:  S Stewart; N F Murphy; N Murphy; A Walker; A McGuire; J J V McMurray
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 10.  Pharmacoeconomics of atrial fibrillation and stroke prevention.

Authors:  Cheryl D Bushnell; David B Matchar
Journal:  Am J Manag Care       Date:  2004-04       Impact factor: 2.229
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.